CLIA CCC key terms

The range of test results expected in a healthy population, usually spanning the central 95 percent of values from a defined reference group. Results outside it are flagged but do not by themselves prove disease.

An automated rule that compares a patient's current result with a previous result from the same patient and flags changes exceeding a set threshold, catching specimen mix-ups, mislabeling, and true acute changes.

A result so far outside normal limits that it may be life-threatening and requires immediate notification of the responsible caregiver, with documentation of who was called, when, and by whom.

A control chart plotting quality control results over time against the mean and standard deviation lines, allowing visual detection of random error, shifts, and trends in an analytical system.

A set of statistical rules such as 1-3s, 2-2s, R-4s, 4-1s, and 10x that decide whether a run is rejected, balancing detection of random and systematic error against false rejection.

The standard deviation divided by the mean, expressed as a percentage. It describes assay imprecision on a scale independent of the analyte's concentration, so assays with different units can be compared.

The smallest amount of analyte an assay can reliably distinguish from zero, often reported as the limit of detection. It describes the method's capability, not its ability to classify patients correctly.

The ability of a method to measure only the intended analyte without interference from related substances, cross-reactants, or matrix effects. It is distinct from diagnostic specificity, which concerns patient classification.

Any substance or condition in the specimen, such as hemolysis, lipemia, icterus, drugs, or heterophile antibodies, that biases a measurement or detection system and produces a result not reflecting the patient's true value.

Contamination of one specimen or reagent by residue from the previous sample on an analyzer's probe or cuvette, producing falsely elevated or depressed results, typically seen in high-then-low sequences.

An external program in which a laboratory analyzes unknown specimens and its results are compared with peer laboratories and the assigned value, serving as a required check on analytical performance under CLIA.

A certificate permitting a laboratory to perform only waived tests, which are simple and low risk. The laboratory must follow manufacturer instructions and obtain a certificate of waiver, but is exempt from routine inspections.

A test category under CLIA requiring a certificate of compliance or accreditation, with personnel qualification standards, quality control, proficiency testing where available, and biennial inspection or accreditation oversight.

The documented steps taken to resolve a deficiency, such as a failed control, unacceptable proficiency test, or inspection finding, including root cause analysis and verification that the fix worked.

A documented, unbroken record of who collected, handled, transported, and stored a specimen or evidence, used for forensic, drug testing, and legal purposes where specimen identity must be provable.

Infection control practices applied to all patients regardless of diagnosis, including hand hygiene, gloves, gowns, masks, eye protection, and safe handling of sharps and body fluids.

A written program required by OSHA's laboratory standard that describes safe handling of hazardous chemicals, engineering controls, personal protective equipment, spill procedures, and employee training.

Safety Data Sheet: a standardized document, formerly called MSDS, providing hazard, handling, first-aid, and disposal information for a chemical, kept accessible to employees in the workplace.

The difference between measured cations and anions, usually sodium minus chloride and bicarbonate. An elevated gap suggests unmeasured anions such as ketones, lactate, or toxins; a low gap suggests laboratory or paraprotein effects.

The difference between measured osmolality and calculated osmolality. An increased gap suggests unmeasured osmotically active substances such as ethanol, methanol, ethylene glycol, or isopropanol.

The physiologically active fraction of calcium not bound to protein, measured by ion-selective electrode. It is unaffected by albumin concentration and is preferred when protein levels are abnormal.

A spectrophotometric estimate of free hemoglobin in a specimen, reported as a graded score or concentration. It alerts the laboratorian that red cell contents may falsely elevate potassium, LDH, and AST.

The percentage or absolute number of immature red cells in peripheral blood, reflecting bone marrow erythropoietic response. Corrected and absolute values help classify anemia as hypoproliferative or regenerative.

The average volume of circulating red cells, calculated from hematocrit and red cell count or measured directly. It classifies anemia as microcytic, normocytic, or macrocytic and guides further testing.

A fragmented red blood cell seen on a peripheral smear, indicating mechanical hemolysis from conditions such as microangiopathic processes, prosthetic valves, or disseminated intravascular coagulation.

The clotting time of citrated plasma after adding tissue factor and calcium, evaluating the extrinsic and common pathways. It is reported in seconds, as a ratio, or as the INR for warfarin monitoring.

The clotting time after adding a contact activator and calcium, evaluating the intrinsic and common pathways. It is used to screen for factor deficiencies and to monitor unfractionated heparin therapy.

The lowest antimicrobial concentration that visibly inhibits growth of an isolate in vitro, used with breakpoints to classify the organism as susceptible, intermediate, or resistant and guide therapy.

An enzyme produced by some bacteria that hydrolyzes the beta-lactam ring of penicillins and cephalosporins, conferring resistance. Detection tests include chromogenic methods and molecular assays.

A cumulative summary of antimicrobial susceptibility results for a defined period and patient population, used to guide empiric therapy and monitor resistance trends.

The combination of ABO/Rh typing and an antibody detection test performed before transfusion, establishing the patient's blood type and identifying unexpected antibodies requiring antigen-negative units.

A test using anti-human globulin to detect antibodies or complement bound to the patient's own red cells in vivo, helping diagnose autoimmune hemolysis, hemolytic transfusion reactions, and hemolytic disease of the newborn.

The compatibility test between donor red cells and recipient serum before transfusion. Immediate spin detects ABO incompatibility; antiglobulin crossmatch detects clinically significant antibodies.

A method in which an enzyme label attached to an antigen or antibody converts a substrate to a detectable signal, quantifying or detecting the analyte. Common formats include sandwich and competitive assays.

A falsely low or negative immunoassay result caused by very high antibody concentrations saturating antigen sites and preventing sandwich formation. Diluting the specimen can restore a valid result.

A technique using fluorochrome-labeled antibodies to detect antigens in cells or tissue, visualized by fluorescence microscopy. It is used in autoantibody testing and direct detection of pathogens.

The ratio of a urine specimen's density to that of water, reflecting solute concentration and renal concentrating ability. It is measured by refractometry, reagent strip, or osmometry.

An in vitro method that amplifies a specific DNA segment through repeated cycles of denaturation, primer annealing, and extension, enabling detection of minute amounts of target sequence.

In real-time PCR, the amplification cycle at which fluorescence first exceeds a set threshold. Lower values generally indicate higher initial target concentration.

A visual arrangement of an individual's chromosomes by size, centromere position, and banding pattern, used to detect numerical and large structural chromosomal abnormalities.